During the past 30 years, Dr. Marc S. Ernstoff has focused his clinical research on expanding the understanding of the immunobiology of human cancer and the development of new immune therapies. His clinical trials, funded by the National Cancer Institute, were targeted at minimizing regulatory and suppressive pathways, and enhancing existent tumor specific immune function. Dr. Ernstoff earned a Bachelor of Arts in art history at Emory University in 1974 and a Doctor of Medicine from New York University in 1978.
Dr. Ernstoff is senior vice president of clinical investigation, professor and chair of the Department of Medicine, and the Katherine Anne Gioia Chair of Medicine at the Roswell Park Cancer Institute. He is also professor and chair of the Department of Medicine at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. Moreover, Dr. Ernstoff serves as the chief of the Division of Oncology and the professor of medicine in the Department of Medicine at the State University of New York at Buffalo.
A diplomate of the National Board of Medical Examiners and the American Board of Internal Medicine in the subspecialty of medical oncology, Dr. Ernstoff has drawn praise for his research in kidney cancer and melanoma. He has been named among The Best Doctors in America since 1996, and more than two decades later he continues to earn recognition, being listed in New Hampshire Magazine Top Doctors Poll since 2009. Using his experience in cancer research, Dr. Ernstoff has published original research manuscripts in the areas of renal cell cancer, melanoma and immune therapy strategies in journals such as the “International Journal of Cancer,” “Journal of Chemotherapy,” “Journal of Interferon Research, and “Journal of Clinical Immunology.” He is featured in Who’s Who in American Education, Who’s Who in Medicine and Healthcare and Who’s Who in Science and Engineering.
Contact Dr. Marc S. Ernstoff:
